国产美女一牲交,欧美成人看片一区二三区图文,国产一性一交一伦一a片

當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

Adenosine
Adenosine is a nucleoside composed of a molecule of adenine attached to a ribose sugar molecule (ribofuranose) moiety vi
2015-11-23 09:55 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

650.00/5g
05g起訂

I-BET151
I-BET151(GSK1210151A) is a BET bromodomain inhibitor(pIC50=6.1,BRD4); I-BET151 blocks recruitment of BET to chromatin .
2015-11-23 09:54 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/5mg
05mg起訂

Fotemustine
Fotemustine (S 10036) is a nitrosourea alkylating agent approved for use in the treatment of metastasising melanoma.Targ
2015-11-23 09:52 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

418.00/10mg
010mg起訂

Methotrexate
Methotrexate(WR19039; CL14377) can interfere with the growth of certain cells of the body, especially cells that reprodu
2015-11-23 09:50 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1083.00/100mg
0100mg起訂

Vinflunine
Vinflunine is a new vinca alkaloid uniquely fluorinated with the properties of mitotic-arresting and tubulin-interacting
2015-11-23 09:48 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/5mg
05mg起訂

Vidarabine
Vidarabine is an antiviral drug which is active against herpes simplex and varicella zoster viruses.Target: DNA/RNA Synt
2015-11-23 09:47 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1200.00/500mg
0500mg起訂

(+)-JQ-1
(+)-JQ1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for BRD4(1/2).IC50 Value: 77 nM(for BRD4(1)); 33 nM( fo
2015-11-23 09:44 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1289.00/5mg
05mg起訂

K-115 (free base)
K-115, an isoquinolinesulfonamide compound, is a highly selective and potent (IC50 = 31 nM) Rho-kinase inhibitor; is in
2015-11-23 09:42 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

21000.00/100mg
0100mg起訂

Irinotecan (hydrochloride)
Irinotecan Hcl(CPT-11 Hcl) prevents DNA from unwinding by inhibition of topoisomerase 1.Target: Topoisomerase IIrinoteca
2015-11-23 09:40 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/500mg
0500mg起訂

PNU-159682
PNU-159682 is a major bioactive metabolite of Nemorubicin in human liver microsomes;3,000-fold cytotoxic than its parent
2015-11-23 09:39 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

21000.00/100mg
0100mg起訂

OTX-015
OTX-015 is a new potent BRD2/3/4 inhibitor with evident anti-proliferative activity in several cell lines representative
2015-11-23 09:37 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2046.00/5mg
05mg起訂

XL413 (hydrochloride)
XL413 is a potent and selective Cdc7 inhibitor with an IC50 of 3.7 nM, 60-fold selectivity against CK2, 10-fold selectiv
2015-11-23 09:35 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

8370.00/100mg
0100mg起訂

Pemetrexed
Pemetrexed is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respecti
2015-11-23 09:33 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

750.00/100mg
0100mg起訂

USP7-IN-1
USP7-IN-1 is a novel selective and reversible inhibitor of USP7 with IC50 of 33 uM; less or no inhibition on USP5, USP8,
2015-11-23 09:31 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3500.00/5mg
05mg起訂

CBB1007
CBB1007 is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD
2015-11-23 09:29 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2325.00/5mg
05mg起訂

TG101209
TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, ~30-
2015-11-23 09:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/5mg
05mg起訂

Auristatin F
Auristatin F is a cytotoxic tubulin modifier with potent and selective antitumor activity; MMAF analog and cytotoxin in
2015-11-23 09:26 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

15000.00/10mg
010mg起訂

Pemetrexed (disodium)
Pemetrexed disodium is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM,
2015-11-23 09:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2070.00/500mg
0500mg起訂

TZ9
TZ9 is a novel inhibitor of Rad6 ubiquitin conjugating enzyme(E2 enzyme); inhibits MDA-MB-231 cell proliferation with IC
2015-11-23 09:22 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1100.00/5mg
05mg起訂

HY-13781
Pemetrexed is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respecti
2015-11-23 09:20 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]